Status:
COMPLETED
Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
COVID
Eligibility:
All Genders
Brief Summary
The ongoing Coronavirus (Covid-19) pandemic is causing a major global health crisis and is shaking up hospital organizations. To date, the recognized risk factors for severe forms of Covid-19 infectio...
Eligibility Criteria
Inclusion
- \- Patient (of all ages) with symptoms compatible with infection by Covid-19 treated at the GHPSJ or in one of the establishments in the Paris Plaisance hospital city.
Exclusion
- Asymptomatic patient
- Patient objecting to the use of their data
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 6 2023
Estimated Enrollment :
3767 Patients enrolled
Trial Details
Trial ID
NCT04365530
Start Date
April 1 2020
End Date
March 6 2023
Last Update
March 7 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Marie Lannelongue
Le Plessis-Robinson, France, 92350
2
AURA Paris Plaisance
Paris, France, 75014
3
Fondation Sainte-Marie
Paris, France, 75014
4
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014